|
DUSP12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.470400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.722000E-01 |
| Normal-vs-Stage2 |
8.648000E-01 |
| Normal-vs-Stage3 |
3.379800E-01 |
| Normal-vs-Stage4 |
4.474200E-01 |
| Stage1-vs-Stage2 |
8.860000E-01 |
| Stage1-vs-Stage3 |
2.842200E-01 |
| Stage1-vs-Stage4 |
4.295400E-01 |
| Stage2-vs-Stage3 |
2.934600E-01 |
| Stage2-vs-Stage4 |
4.106800E-01 |
| Stage3-vs-Stage4 |
8.092800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.680600E-01 |
| Normal-vs-AfricanAmerican |
5.603600E-01 |
| Normal-vs-Asian |
3.252600E-01 |
| Caucasian-vs-AfricanAmerican |
7.080400E-01 |
| Caucasian-vs-Asian |
3.589800E-01 |
| AfricanAmerican-vs-Asian |
2.438800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.769600E-01 |
| Normal-vs-Female |
5.962100E-02 |
| Male-vs-Female |
4.740700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.622400E-01 |
| Normal-vs-Extreme_Weight |
6.036800E-01 |
| Normal-vs-Obese |
5.819600E-01 |
| Normal-vs-Extreme_Obese |
1.386990E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.981600E-02 |
| Normal_Weight-vs-Obese |
5.465800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.113900E-02 |
| Extreme_Weight-vs-Obese |
1.952400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.210800E-01 |
| Obese-vs-Extreme_Obese |
1.163630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.384100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.217800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.547200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.534380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.844100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.054340E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.514330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.932980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.002000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.936440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.621800E-01 |
| Normal-VS-Type2 PRCC |
3.540800E-01 |
| Normal-VS-KIRP CIMP |
1.260430E-01 |
| Normal-VS-Unclassified PRCC |
6.966200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.508400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.482640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.229800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.016500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.917360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.656000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.479610E-01 |
| Normal-vs-N1 |
3.840400E-02 |
| Normal-vs-N2 |
3.932400E-01 |
| N0-vs-N1 |
6.995500E-03 |
| N0-vs-N2 |
7.445800E-01 |
| N1-vs-N2 |
1.900030E-01 |
|
|
